Frank W. Haydu
Director/Board Member at iParty Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David E. Robertson | M | 74 |
iParty Corp.
 iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 17 years |
| Sal V. Perisano | M | 73 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 26 years |
| Dorice P. Dionne | F | 72 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 26 years |
| Dan I. DeWolf | M | 67 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Corrigan | M | 66 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | 5 years |
| Alexis Borisy | M | 52 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 9 years |
| Jason Cole | M | 51 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 8 years |
| Christopher C. Gallen | M | 72 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 3 years |
| Hartley Richardson | M | 69 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 3 years |
| Jim O'Shea | M | 74 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 7 years |
| Amit Munshi | M | 56 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Sally Crawford | F | 70 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 7 years |
| Justin Renz | M | 52 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 8 years |
| Bill Hunter | M | 61 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | 1 years |
| J. Buchi | M | 69 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Scott Rocklage | M | 69 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Robert M. Forrester | M | 60 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 6 years |
| Roger Brooks | M | 79 |
Moldflow Corp.
 Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 10 years |
| Curtis T. Keith | M | 53 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 8 years |
| Sue E. MacCormack | F | 67 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | - |
| Eric Schindler | M | 63 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 8 years |
| Lynn G. Baird | M | 76 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 3 years |
| Christopher L. Gorgone | M | 74 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 2 years |
| Michael Wyand | M | 68 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Joseph Vassalluzzo | M | 75 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 9 years |
| Marc J. L. Dulude | M | 64 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 5 years |
| Geoff Duyk | M | 64 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Patrick F. Farrell | M | 56 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 8 years |
| Marc Joseph Luc Dulude | M | - |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 6 years |
| Michael Kauffman | M | 60 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | 8 years |
| Barbara H. Deptula | F | 69 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 4 years |
| Hal Lubsen | M | 82 |
Muhlenberg College
| 4 years |
| Kenneth Huttner | M | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 2 years |
| Dao Tian Fu | M | 61 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Peter Elliott | M | 64 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 4 years |
| William Tamul | M | - |
Valuation Perspectives, Inc.
| 4 years |
| Terrance P. Snutch | M | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | - |
| Christine Bunt | F | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 3 years |
| Paul Brannelly | M | 51 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 3 years |
| Robert Whelan | M | 72 |
Valuation Perspectives, Inc.
| 4 years |
| C. Eugene Wright | M | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | - |
| Gina Nugent | F | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | - |
| Robert L. Kross | M | 70 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | - |
| Jessica Anderson | F | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 3 years |
| Christina W. Vest | F | 52 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 7 years |
| Jennifer M. Cermak | M | 51 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 4 years |
| Mitchell Eisenberg | M | - |
Muhlenberg College
| 4 years |
| Richard Frederick Brueckner | M | 74 |
Muhlenberg College
| 4 years |
| Richard Pops | M | 62 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 8 years |
| Ian M. Pendlebury | M | 60 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 23 years |
| Timothy Triplett | M | 67 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 2 years |
| George M. Bado | M | 69 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | - |
| R. Eric McAllister | M | 82 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 2 years |
| Daniel S. Grau | M | 57 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 7 years |
| John Randle | M | 66 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 2 years |
| Mitchell Keegan | M | 52 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 4 years |
| Kim Seth | M | - |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Robert J. Lepofsky | M | 79 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 5 years |
| Robert Schechter | M | 76 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 8 years |
| Rob W. Jevon | M | 71 |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | 3 years |
| Thomas A. Shea | M | 64 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Christopher Moller | M | 71 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | - |
| Peter K. Kennedy | M | 69 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | 21 years |
| Douglas Cole | M | 63 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
| Jan N. Lessem | M | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 4 years |
| Patrick J. Fortune | M | 77 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 3 years |
| Jacob Goldfield | M | - |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | - |
| Todd Foley | M | 52 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | 4 years |
| Carl Bass | M | 67 |
Moldflow Corp.
Moldflow Corp. Information Technology ServicesTechnology Services Moldflow Corp. offers software, hardware, and material characterization solutions which optimize injection molded plastic products in all phases of the product design to manufacture process. Its products and services help to reduce operating cost of the manufacturing process and streamline the product introduction process. The company is headquartered in Framingham, MA. | - |
| Marty Hernon | M | - |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | - |
| Lorenzo Roccia | M | - |
iParty Corp.
iParty Corp. Specialty StoresRetail Trade iParty Corp. operates party goods retail stores. It offers assortment of products such as paper party goods, Halloween costumes, greeting cards, balloons and also merchandise. Its merchandise includes piñatas, tiny toys and masquerade and Hawaiian Luau items. It operates in a single segment as a retailer of party goods. The company was founded by Sal Perisano and Dorice Dionne on March 12, 1998 and is headquartered in Dedham, MA. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 71 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank W. Haydu
- Personal Network
